Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05782114
Other study ID # P.T.REC/012/004162
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2023
Est. completion date August 2024

Study information

Verified date March 2023
Source Cairo University
Contact Mostafa G Mahmoud, phd
Phone 0201122425299
Email darsh9lover@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study will be conducted to explore the efficacy of ESWT on ultrasonographic changes, pain intensity level, upper limb function and hand grip strength in patients with de Quervain tenosynovitis.


Description:

De Quervain tenosynovitis (DQT) is a painful condition involving the tendons of the abductor pollicis longus (APL) and extensor pollicis brevis (EPB). The pathogenesis is generally defined as a stenosing condition of the first dorsal compartment of the wrist, characterized by thickening of the extensor retinaculum of APL and EPB, which can cause tendon gliding difficulties and impingement between the tendons and their fibrous sheaths. The prevalence rate of DQT in the general population is 0.5% for males and 1.3% for females, with peak prevalence at the age of 40-60 years. Female prevalence is 6 to 10 times higher than that in men. De Quervain tenosynovitis is a repetitive strain injury consider postures where the thumb is held in abduction and extension to be predisposing factors. De Quervain tenosynovitis incidence increased by virtue of modern life conditions such as excessive computer use and increased use of cellular phones. However, little research has been carried out to determine the therapeutic effects of ESWT in DQT, and up till now, there is a gap in literature that explore ESWT efficacy on ultrasonographic changes of DQT. So This current study will be conducted to explore the efficacy of ESWT on ultrasonographic changes, pain intensity level, upper limb function and hand grip strength in patients with de Quervain tenosynovitis. Sixty patients from both genders will be involved in this study and will be randomly subdivided into two equal groups in number. First Group (A) (Experimental Group) will receive radial Extracorporeal Shockwave therapy plus Traditional physical therapy program and the second Group (B) (Control Group): This group will receive Traditional physical therapy program.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2024
Est. primary completion date April 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Age from 18 to 65 years 2. Both genders (males and females). 3. Normal BMI ranges between 18.5:24.9 kg/m2. 4. Patients will be referred from an orthopedist with diagnosis of DQT. 5. Chronic pain more than 2 months. 6. No history of undergoing physiotherapy modalities or corticosterone injection therapies for any reasons during the past month. 7. De Quervain tenosynovitis patients will be diagnosed based on the standard criteria, including pain and tenderness in the lateral wrist and a positive result for the Finkelstein test. Exclusion Criteria: 1. History of undergoing physiotherapy modalities or corticosterone injection therapies for any reason during the past month. 2. Subjects with other neurological disorders rheumatologic diseases causing wrist pain. 3. Pregnancy. 4. History of fracture or surgery on the hand. 5. Severe trauma, and coagulation disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Extracorporeal Shockwave therapy
The shockwave will be applied for the experimental group (Group A). The patients will be positioned on a chair, and the hand with the disorder will be placed on a surface with the radio ulnar joint will be in mid position and the thumb will be directed up. will be 1000 impulses with 2 bar pressure at a frequency of 15 Hz on the radial head and focused on the tissue surrounding the maximal pain point.
Traditional physical therapy program
Instruction to wear Thumb Spica splint: The Thumb Spica splint will be used for 4 weeks for both groups of patients. Ultrasound Therapy: Therapeutic Ultrasound parameters will be mode: continuous, duration: 5 minutes, intensity: 1.2watt/cm2 and frequency: 1MHZ. Stretching exercise: 1. Self-stretch of the thenar eminence: 2. Opposition stretches: 3. Wrist stretch: 4) Strengthening exercise: Resisted exercise for thumb extension: Resisted exercise for thumb abduction: Resisted exercise for thumb opposition: Wrist radial deviation strengthening: Grip strengthening: Finger spring:

Locations

Country Name City State
Egypt Mostafa Gomaa Mahmoud Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ultrasonographic Changes: Thickness in tendons: Ultrasonography which is a valid and reliable measure to evaluate tendon structural changes including:
Tendon thickness APL & EPB tendons in mm.
Thickness of hypoechoic area in mm.
Up to Four weeks
Primary Ultrasonographic Changes: Color Doppler activity Ultrasonography Up to Four weeks
Secondary Pain intensity level assessment : VAS will be used by the patient to mark his/her level of pain on visual analogue scale. Up to Four weeks
Secondary Assessment of upper limb function: by Q-DASH (The Arabic Quick-DASH questionnaire) is an 11-item self-report questionnaire extracted from the full-length version of the DASH concerning the patient's health status. Up to Four weeks
Secondary Handgrip Strength assessment: Baseline hydraulic hand dynamometer Hand grip strength as a measure of functional performance will be measured using the Baseline hydraulic hand dynamometer (Baseline®, Irvington, NY, USA). Up to Four weeks
Secondary Pinch grip Strength assessment: The key pinch will be tested with a Baseline hydraulic pinch gauge (Baseline®, Irvington, NY, USA) Up to Four weeks
See also
  Status Clinical Trial Phase
Completed NCT05692583 - Correlation Between EPB Entrapment Test and Ultrasound Wrist Findings in Patients With deQuervain's Disease
Recruiting NCT05261737 - Steroid Injection in De Quervain Tenosynovitis
Completed NCT05141799 - Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis N/A
Completed NCT05423353 - Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis N/A
Completed NCT05423223 - Comparative Effects of Paraffin Bath Therapy and ESWT on Quality of Life and Sleep in De Quervain Tenosynovitis N/A
Not yet recruiting NCT06012097 - Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease Phase 4
Completed NCT04384536 - Evaluation of Effectiveness of Local Anesthetic Injection in Patients With De Quervain Tenosynovitis N/A
Completed NCT04260984 - Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease N/A
Recruiting NCT06296472 - De Quervain's Disease in the Acute Phase:a Study Aimed at Evaluating the Effectiveness of Standard Physiotherapy Treatment (HANDGUIDE), Compared to Experimental Treatment After Performing Ultrasound-guided Infiltrative Therapy. N/A
Terminated NCT02029235 - Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Phase 4
Terminated NCT04069741 - Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention N/A
Completed NCT03111186 - Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery Phase 2